A Feasibility Study Evaluating Mindfulness-Based Intervention Assessing- A Wearable Wellness Brain Sensing Device (Muse-S) in Newly Diagnosed Fibromyalgia Patients.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Fibromyalgia
- Sponsor
- Mayo Clinic
- Enrollment
- 44
- Locations
- 1
- Primary Endpoint
- Change in Widespread Pain Index (WPI)
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
The purpose of this study is to study the feasibility of a wearable brain sensing wellness device to provide mindfulness training to fibromyalgia patients who have failed medical therapy.
Detailed Description
All study participants will receive a wearable brain sensing wellness device, and demonstration of the mindfulness sessions. Participants will be asked to complete study surveys/questionnaires. During the first part of study, participants will be asked to complete the intervention. After completion of the intervention they will enter a follow-Up Phase, where they will be contacted and asked to complete surveys and gauge satisfaction with the study.
Investigators
Sanjeev Nanda
Principal Investigator
Mayo Clinic
Eligibility Criteria
Inclusion Criteria
- •18 years of age or older at time of consent.
- •Diagnosed with Fibromyalgia.
- •Not pregnant by subject self-report at time of consent.
- •Have the ability to provide informed consent.
- •Have the ability to complete all aspects of this trial.
- •Have access to a iPhone, iPad, Android device.
- •Has no contraindicating comorbid health condition as determined by the clinical investigators.
Exclusion Criteria
- •Used or been enrolled in any treatments for fibromyalgia, or pain within the past 30 days.
- •Used an investigational drug within the past 30 days.
- •Currently (within the past 3 weeks) been practicing mindfulness training on a weekly/regular basis.
- •Currently (within the past 3 weeks) been undergoing an additional program (e.g. CAM) to improve quality of life.
- •Currently (within 3 weeks) been enrolled in another clinical or research program (e.g. CAM) which intervenes on the patients' QOL, or stress.
- •An unstable medical or mental health condition as determined by the physician investigator.
Outcomes
Primary Outcomes
Change in Widespread Pain Index (WPI)
Time Frame: Baseline to end of treatment (day 90)
Wide pain index (WPI) defined as a 4-quadrant plus axial pain, measuring widespread pain in 19 body areas where the patient feels pain over the prior week. Each area identified on the list counts as 1. The range on the WPI score can range from 0 to 19. With lower number indicating fewer areas of pain (hence lower pain). The difference is calculated by taking the baseline score minus the end of treatment score.
Change in Perceived Stress Scale
Time Frame: Baseline to end of treatment (day 90)
Measured on a 0-10 pain assessment scale. Participants rate their stress on a scale of 0 to 10. Zero means "no stress," and 10 means "the worst possible stress". The difference is calculated by taking the baseline score minus the end of treatment score.